The article explores the history of potential treatment for haemophilia and the development of Hyate:C. It mentions that bovine and porcine preparations were used initially in treating patients with haemophilia A and not only those developing inhibitors to factor VIII. The first released report of the clinical use of Hyate:C introduced in 1984 and discussed the successful application of Hyate:C in eight patients over an 18-month period.